|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-12-13
|
|
pubmed:abstractText |
Therapeutic options for patients with treatment-resistant schizophrenia are limited, and combination treatment with atypical antipsychotic drugs is an often used strategy. We tested the hypothesis that the combination of aripiprazole and clozapine would lead to an improvement in this patient group.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1173-2563
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
117-24
|
|
pubmed:meshHeading |
pubmed-meshheading:17163242-Adult,
pubmed-meshheading:17163242-Clozapine,
pubmed-meshheading:17163242-Drug Resistance,
pubmed-meshheading:17163242-Drug Therapy, Combination,
pubmed-meshheading:17163242-Female,
pubmed-meshheading:17163242-Humans,
pubmed-meshheading:17163242-Male,
pubmed-meshheading:17163242-Middle Aged,
pubmed-meshheading:17163242-Piperazines,
pubmed-meshheading:17163242-Quinolones,
pubmed-meshheading:17163242-Receptors, Dopamine D2,
pubmed-meshheading:17163242-Schizophrenia
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.
|
|
pubmed:affiliation |
Department of Social Psychiatry and Psychotherapy, Hannover Medical School (MHH), Hannover, Germany. ziegenbein.marc@mh-hannover.de
|
|
pubmed:publicationType |
Journal Article
|
